After several years of outstanding development, Zhenjiang Zhongzhi Chemical Technology Co., Ltd. has evolved into a CRO company integrating independent R&D, production, and marketing. The company primarily engages in high-tech R&D outsourcing and the synthesis of high-value-added pharmaceutical intermediates.

The company's R&D is led by a team of doctors from the Institute of Organic Chemistry, with extensive experience from companies such as Novartis. Adopting an international management model and operational philosophy, the company integrates China's chemical resources and excellent local R&D talent, focusing on the independent development of high-value-added, export-oriented pharmaceutical intermediates as its main direction. The company emphasizes the R&D and application of new products and technologies, including process research and development, as well as the production of active pharmaceutical ingredients (APIs) from small-scale and pilot-scale to industrial-scale production. Products are primarily sold to high-end international markets. The company has earned high recognition from numerous internationally renowned professional firms for its strong R&D capabilities, high-quality products, and excellent customer service, becoming a key supplier for many. It boasts a modern R&D center, GMP and FDA collaborative production bases, and established a cGMP testing center in 2020 (equipped with large-scale testing instruments such as NMR and GC-MS) to support high-standard product manufacturing.

We firmly believe that through our efforts, the company will become a pioneer and leader in the pharmaceutical intermediates industry and the high-end production outsourcing services sector. We strive to surpass Western competitors and become a major player in the market.